236 related articles for article (PubMed ID: 21466646)
1. Poor adherence to integral daily tasks limits the efficacy of CSII in youth.
O'Connell MA; Donath S; Cameron FJ
Pediatr Diabetes; 2011 Sep; 12(6):556-9. PubMed ID: 21466646
[TBL] [Abstract][Full Text] [Related]
2. Objectively Measured Adherence in Adolescents With Type 1 Diabetes on Multiple Daily Injections and Insulin Pump Therapy.
Westen SC; Warnick JL; Albanese-O'Neill A; Schatz DA; Haller MJ; Entessari M; Janicke DM
J Pediatr Psychol; 2019 Jan; 44(1):21-31. PubMed ID: 30184209
[TBL] [Abstract][Full Text] [Related]
3. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes.
Olinder AL; Kernell A; Smide B
Pediatr Diabetes; 2009 Apr; 10(2):142-8. PubMed ID: 19175898
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus.
Orr CJ; Hopman W; Yen JL; Houlden RL
Diabetes Technol Ther; 2015 Jan; 17(1):49-54. PubMed ID: 25317602
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM
Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546
[TBL] [Abstract][Full Text] [Related]
7. Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
Halbron M; Bourron O; Andreelli F; Ciangura C; Jacqueminet S; Popelier M; Bosquet F; Rouanet S; Amouyal C; Hartemann A
Diabetes Technol Ther; 2019 Jul; 21(7):409-412. PubMed ID: 31265349
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
9. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
11. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
Nixon R; Pickup JC
Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey.
Roze S; Smith-Palmer J; de Portu S; Özdemir Saltik AZ; Akgül T; Deyneli O
Diabetes Technol Ther; 2019 Dec; 21(12):727-735. PubMed ID: 31509715
[No Abstract] [Full Text] [Related]
14. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
16. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
[TBL] [Abstract][Full Text] [Related]
17. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
[TBL] [Abstract][Full Text] [Related]
18. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
[No Abstract] [Full Text] [Related]
19. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
[TBL] [Abstract][Full Text] [Related]
20. Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII Treatment.
van Meijel LA; van den Heuvel-Bens SP; Zimmerman LJ; Bazelmans E; Tack CJ; de Galan BE
Clin Ther; 2018 Jun; 40(6):862-871. PubMed ID: 29502804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
